Wednesday, November 8, 2006

A Comparison of 3-D Conformal Proton Therapy, Intensity Modulated Proton Therapy, and Intensity Modulated Photon Therapy for Retroperitoneal Sarcoma Presenter: Christine S. ChungPresenter's Affiliation: Harvard Radiation Oncology Program, Boston, MAType of Session: ScientificBackground The treatment of retroperitoneal sarcoma usually involves a combination of surgery and radiotherapy. ...
Adjuvant Chemoradiation for Adenocarcinoma of the Pancreas: The Johns Hopkins Experience Presenter: M.J. SchwartzPresenter's Affiliation: Johns Hopkins University School of Medicine, Baltimore, MDType of Session: ScientificBackground At time of initial presentation, 15% to 20% of patients will have resectable pancreatic cancers. ...
Adjuvant Chemoradiation for Adenocarcinoma of the Pancreas: The Johns Hopkins Experience Adjuvant Chemoradiation for Adenocarcinoma of the Pancreas: The Johns Hopkins Experience At the time of diagnosis, 15% to 20% of patients will have resectable pancreatic cancers. The 5-year survival for patients after surgical resection is between...
Cardiac Morbidity and Mortality After Breast Conservation Treatment in Early-stage Breast Cancer Patients With Pre-existing Cardiac Disease Presenter: R. GuttPresenter's Affiliation: University of MarylandType of Session: ScientificBackground Patients with left-sided breast cancer have been shown to have an increase in the subsequent development of coronary artery disease (CAD) and...
Cetuximab in Combination With Capecitabine, Oxaliplatin, and Concomitant Radiotherapy (Cet-Capox-RT) as Preoperative Therapy for Rectal Cancer Presenter: C. RoedelPresenter's Affiliation: Universityeristat Erlangen, Erlangen, GermanyType of Session: ScientificBackground Cetuximab is a monoclonal antibody to the EGF-receptor. Cetuximab has been shown to improve outcomes in...
Cetuximab in Combination With Capecitabine, Oxaliplatin, and Concomitant Radiotherapy (Cet-Capox-RT) as Preoperative Therapy for Rectal Cancer Cetuximab in Combination With Capecitabine, Oxaliplatin, and Concomitant Radiotherapy (Cet-Capox-RT) as Preoperative Therapy for Rectal Cancer Cetuximab is a monoclonal antibody to the EGF-receptor and has been shown to improve outcomes in...
Elective Nodal Irradiation in the Treatment of Non-Small Cell Lung Cancer Presenter: K.E. RosenzweigPresenter's Affiliation: Memorial Sloan Kettering Cancer Center, NY, NYType of Session: ScientificBackground It is difficult to know which nodal regions need irradiation when treating lung cancer with radiotherapy. ...
Impact of Prophylactic Cranial Irradiation on Neurocognitive Function in Patients With Small Cell Lung Carcinoma Presenter: D.R. GrosshansPresenter's Affiliation: MD Andersen Cancer Center, Houston, TXType of Session: ScientificBackground Numerous reports have shown that limited-stage small cell lung cancer patients who receive prophylactic cranial...
Phase II Study of Proton Radiotherapy for Spine and Paraspinal Sarcoma Presenter: Thomas F. DelaneyPresenter's Affiliation: Massachusetts General Hospital, Boston, MAType of Session: ScientificBackground Sarcomas located in the spinal axis have a poor prognosis, as local control of the disease is difficult to...
Role of PI3K/Akt Signaling in TRAIL and Radiation-induced Gastrointestinal (GI) Apoptosis Presenter: J. PlastarasPresenter's Affiliation: University of PennsylvaniaType of Session: ScientificBackground Activation of the PI3K/Akt pathway leads to tumorigenesis, progression, and resistance to therapy; inhibition of the PI3K/Akt...